Long‐term follow‐up of patients undergoing percutaneous suprapubic tube drainage after robot‐assisted radical prostatectomy (RARP)
Study Type – Therapy (case series) Level of Evidence 4 What's known on the subject? and What does the study add? • Initial reports of percutaneous suprapubic tube (PST) drainage following RARP demonstrated feasibility and short‐term safety, while decreasing patient discomfort and utilization o...
Saved in:
Published in | BJU international Vol. 110; no. 4; pp. 580 - 585 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.08.2012
Wiley-Blackwell Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
ISSN | 1464-4096 1464-410X 1464-410X |
DOI | 10.1111/j.1464-410X.2011.10786.x |
Cover
Loading…
Summary: | Study Type – Therapy (case series)
Level of Evidence 4
What's known on the subject? and What does the study add?
•
Initial reports of percutaneous suprapubic tube (PST) drainage following RARP demonstrated feasibility and short‐term safety, while decreasing patient discomfort and utilization of anti‐cholinergic medication.
•
This study demonstrates the long‐term safety and efficacy of bladder drainage by PST; splinting the urethrovesical anastomosis is simply not essential if mucosal apposition is ensured.
OBJECTIVES
•
To evaluate the long‐term safety and functional outcomes of patients undergoing percutaneous suprapubic tube (PST) drainage after robot‐assisted radical prostatectomy (RARP).
PATIENTS AND METHODS
•
Between January 2008 and October 2009, 339 patients undergoing RARP by one surgeon experienced in RA surgery (M.M.) had postoperative bladder drainage with PST and a minimum of 1‐year follow‐up for urinary function.
•
Functional outcomes were obtained via patient‐administered questionnaire.
•
Complications were captured by exhaustive review of multiple datasets, including our prospective prostate cancer database, claims data, as well as electronic medical and institutional morbidity and mortality records.
RESULTS
•
Urinary function assessed by patient‐administered questionnaire was analysed at a mean (sd) follow‐up of 11.5 (1.7) months; after RARP with PST placement, 293 patients (86.4%) had total urinary control and only nine (2.7%) required >1 pad/day.
•
In all, 86 patients (25.4%) never wore a pad; the median time to 0–1 pad/day was 2 weeks (interquartile range [IQR] 0,6); median time to total control was 6 weeks (IQR 1,22).
•
The mean (sd) follow‐up for complications was 23.7 (6.1) months. In all, 15 patients (4.4%) had a procedure‐specific complication, of which 13 were minor (Clavien Class I/II 3.8%); one patient had a bladder neck contracture.
•
In all, 16 patients (4.7%) required Foley placement after RARP for gross haematuria (two patients), urinary retention (three), tube malfunction (four) or need for prolonged Foley catheterization (seven).
CONCLUSIONS
•
PST placement after RARP is safe and efficacious on long‐term follow‐up.
•
Splinting of the urethrovesical anastomosis is not a critical step of RP if a watertight anastomosis and excellent mucosal apposition are achieved. |
---|---|
Bibliography: | J.D.S. and Q.‐D.T. contributed equally. ObjectType-Article-1 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Article-2 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 |
ISSN: | 1464-4096 1464-410X 1464-410X |
DOI: | 10.1111/j.1464-410X.2011.10786.x |